Disorders of optic nerve and visual pathways

H7_OPTNERVE

optic neuritis: Optic neuritis is inflammation of the optic nerve, the nerve that carries the visual signal from the eye to the brain.The conditionmay cause sudden, reduced vision in the affected eye(s). While the cause of optic neuritis is unknown, it has been associated with autoimmune diseases, infections, multiple sclerosis , drug toxicity and deficiency of vitamin B-12. Vision often returns to normal within 2-3 weeks without treatment. In some cases, corticosteroids are given to speed recovery. If known, the underlying cause should be treated.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H46-H48 Cause of death: ICD-10 — H46-H48 2 out of 7 registries used, show all original rules.	3574
4. Check minimum number of events None	3574
5. Include endpoints H7_OPTNEURITIS H7_OPTNEUROTH H7_RETROBULBNEURINOTH H7_OPTNERVPATHINOTH	3892
6. Filter based on genotype QC (FinnGen only)	3892

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	H7_OPTNERVE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_OPTNEURITIS\|H7_OPTNEUROTH\|H7_RETROBULBNEURINOTH\|H7_OPTNERVPATHINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H4[6-8]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H4[6-8]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of optic nerve and visual pathways based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	27317	15860	11283
Only index persons	24341	14506	9835
Unadjusted period prevalence (%)
Whole population	0.40	0.45	0.32
Only index persons	0.47	0.53	0.38
Median age at first event (years)
Whole population	42.35	40.11	45.40
Only index persons	41.50	39.25	44.83

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3892	2535	1357
Unadjusted period prevalence (%)	0.77	0.86	0.60
Median age at first event (years)	44.75	40.10	53.45

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3473: Matched controls
34729

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H47.3

ICD-10 Finland

Other disorders of optic disc

2104.5

323.0

397

L03AB07

ATC

interferon beta-1a; parenteral

104.9

323.0

366

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

91.3

323.0

574

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

9.6

323.0

918

1252

109

Kela drug reimbursment

Multiple sclerosis

90.8

323.0

693

H47.2

ICD-10 Finland

Optic atrophy

6184.5

323.0

537

XCK00

NOMESCO Finland

Perimetry

16.6

323.0

1036

866

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

+∞

323.0

597

H47.1

ICD-10 Finland

Papilloedema, unspecified

8565.0

323.0

700

G35

ICD-10 Finland

Multiple sclerosis

75.3

323.0

851

149

H46

ICD-10 Finland

Optic neuritis

10071.6

323.0

1308

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

93.4

323.0

611

Z01.0

ICD-10 Finland

Examination of eyes and vision

5.5

323.0

1201

3043

TAB00

NOMESCO Finland

Lumbar puncture

11.2

307.1

619

662

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

6.7

258.2

729

1323

L03AX13

ATC

glatiramer acetate; parenteral

87.9

246.7

275

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

13.0

221.1

407

350

N86

ICPC

Multiple sclerosis

57.2

219.1

260

XCW99

NOMESCO Finland

Other investigative procedure of eye

5.2

214.6

758

1776

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

49.8

213.0

259

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

11.2

195.3

387

385

H53.4

ICD-10 Finland

Visual field defects

16.7

187.0

308

201

164

Kela drug reimbursment

Fingolimod

112.8

186.3

202

XCD10

NOMESCO Finland

Electrophysiological examination of eye

13.0

185.9

341

288

XCK10

NOMESCO Finland

Photography of fundus of eye

5.0

182.8

661

1564

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

6.6

179.0

499

861

353

Kela drug reimbursment

Cladribine and fingolimod

116.5

163.8

177

G93.2

ICD-10 Finland

Benign intracranial hypertension

148.9

160.9

170

L04AX07

ATC

dimethyl fumarate; oral

66.5

158.0

183

L04AA27

ATC

fingolimod; oral

115.8

143.3

155

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

11.5

139.2

270

253

L04AA31

ATC

teriflunomide; oral

111.9

138.2

150

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

43.1

137.6

172

CS494

NOMESCO Finland

Other visual field testing

12.1

133.5

252

223

L03AB08

ATC

interferon beta-1b; parenteral

77.9

131.6

149

H53.1

ICD-10 Finland

Subjective visual disturbances

4.9

125.1

442

994

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.2

121.7

518

1401

N04BB01

ATC

amantadine; oral

12.8

112.5

206

170

N07XX09

ATC

[U] dimethyl fumarate; oral

72.4

110.3

126

36703

ICD-8 Finland

Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris

+∞

108.9

104

S01EC01

ATC

acetazolamide; systemic

10.7

108.4

217

215

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

24.0

106.7

154

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

+∞

95.2

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

9.6

90.8

192

210

M03BX01

ATC

baclofen; systemic

10.0

84.8

175

183

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.4

80.8

432

1389

2AB04

NOMESCO Finland

68.1

80.8

XA800

NOMESCO Finland

Neuropsychological investigation

4.6

78.3

290

673

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

119.9

76.2

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

17.4

75.6

121

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

8.5

69.8

158

194

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

10.4

69.7

140

139

AA1AD

NOMESCO Finland

CT of head and brain

2.2

66.6

829

4337

3773B

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]

+∞

64.8

H53.9

ICD-10 Finland

Visual disturbance, unspecified

5.4

62.6

199

390

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

34.5

62.2

R51.80

ICD-10 Finland

Headache

2.3

58.2

651

3215

ZX120

NOMESCO Finland

Intravenous

2.8

58.1

411

1584

G36.0

ICD-10 Finland

Neuromyelitis optica [Devic]

296.8

57.4

H47.7

ICD-10 Finland

Disorder of visual pathways, unspecified

556.8

55.7

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

7.0

54.7

140

208

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

70.0

54.3

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

56.4

51.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

51.6

1353

9190

XKD06

NOMESCO Finland

Physiologic investigation of micturition

5.1

51.3

169

345

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

25.1

49.0

N03AX12

ATC

gabapentin; oral

2.2

48.2

557

2769

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

10.2

46.8

L03AB13

ATC

peginterferon beta-1a; parenteral

59.8

45.4

4AA23

NOMESCO Finland

158.7

44.9

N06BA07

ATC

modafinil; oral

19.2

44.5

H02AB06

ATC

prednisolone; systemic

1.7

44.3

1527

11089

36702

ICD-8 Finland

Inflammation of optic nerve and retina, Neuritis optica. Papillitis

+∞

43.8

H57.1

ICD-10 Finland

Ocular pain

3.9

43.3

189

509

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

10.0

42.3

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

42.1

294

1117

XKD00

NOMESCO Finland

Uroflowmetry

2.2

41.6

469

2293

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

6.1

40.8

114

191

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

9.6

40.6

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

20.3

40.1

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

6.6

40.0

105

162

E23.00

ICD-10 Finland

Panhypopituitarism

18.8

39.7

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

39.1

259

950

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.1

39.1

228

769

A02BC02

ATC

pantoprazole; systemic

1.6

38.9

2062

16556

ZXA10

NOMESCO Finland

Bilateral

1.9

38.7

642

3672

G04BD09

ATC

trospium; oral

5.1

38.6

127

259

N03AX16

ATC

pregabalin; oral

1.8

38.1

764

4663

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

7.6

36.8

119

H02AB04

ATC

methylprednisolone; systemic

2.0

36.4

505

2690

H02AB09

ATC

hydrocortisone; systemic

4.6

36.2

131

296

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

36.1

291

1198

H53.2

ICD-10 Finland

Diplopia

4.0

36.1

150

387

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

35.9

1236

8814

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

5.6

34.5

104

192

3773A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]

+∞

34.4

37799

ICD-8 Finland

Other diseases of retina and optic nerve, Unspecified

+∞

34.4

N03AE01

ATC

clonazepam; systemic

2.8

34.3

230

848

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

33.9

355

1670

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.2

33.8

362

1722

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

33.4

406

2045

101

Kela drug reimbursment

Anterior pituitary hypofunction

9.3

32.5

UKC02

NOMESCO Finland

Cystoscopy

2.0

32.4

478

2602

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

7.4

31.6

104

34099

ICD-8 Finland

Multiple sclerosis

48.0

31.6

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

6.2

31.0

140

XKC03

NOMESCO Finland

Water cystometry

3.7

31.0

140

389

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.7

30.9

216

820

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

30.8

925

6306

L04AX01

ATC

azathioprine; systemic

2.9

30.6

191

672

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

10.2

30.6

G04BD12

ATC

mirabegron; oral

2.3

30.5

313

1456

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

30.3

657

4073

R1250

NOMESCO Finland

Evaluation of functional capability

4.4

30.2

112

260

L04AA40

ATC

cladribine; oral

83.3

29.8

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

9.3

29.6

37790

ICD-8 Finland

Other diseases of retina and optic nerve, Atrophia (et degeneratio) nervi optici (tabica excepta)

+∞

29.2

N05CF01

ATC

zopiclone; oral

1.6

27.3

953

6713

SPAT1229

SPAT

Assessment of need for aid

2.4

27.1

245

1071

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

27.0

506

2983

H54.4

ICD-10 Finland

Blindness, monocular

20.2

26.9

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.1

26.6

106

264

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

8.2

26.3

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.4

26.1

152

H47.4

ICD-10 Finland

Disorders of optic chiasm

+∞

26.1

H54.7

ICD-10 Finland

Unspecified visual loss

9.0

25.4

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

6.2

25.4

113

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

15.9

25.4

G04BD04

ATC

oxybutynin; oral, transdermal

2.7

25.3

185

719

H48.1

ICD-10 Finland

Retrobulbar neuritis in diseases classified elsewhere

+∞

25.0

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

24.8

432

2480

H52.1

ICD-10 Finland

Myopia

3.1

24.8

143

480

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

24.7

205

856

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

8.4

24.5

N02BE01

ATC

paracetamol; systemic, rectal

1.6

24.5

2772

24930

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.0

24.0

143

490

R33

ICD-10 Finland

Retention of urine

2.4

23.9

218

957

TKC22

NOMESCO Finland

Catheterisation instruction

4.4

23.6

202

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

7.5

23.6

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

7.5

23.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

23.6

420

2427

XCH00

NOMESCO Finland

Eye pressure measurement

3.1

23.5

135

452

PAW37

NOMESCO Finland

Biopsy of temporal artery

8.6

23.0

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.9

22.9

252

N03AF02

ATC

oxcarbazepine; oral

3.0

22.7

135

461

R42

ICD-10 Finland

Dizziness and giddiness

1.6

22.5

630

4166

R35

ICD-10 Finland

Polyuria

2.4

22.5

200

867

G91.0

ICD-10 Finland

Communicating hydrocephalus

11.2

22.4

N03AX14

ATC

levetiracetam; systemic

3.4

22.2

111

336

R4110

NOMESCO Finland

Physiotherapy

1.5

22.1

791

5558

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

9.9

22.0

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

6.5

21.9

R50.9

ICD-10 Finland

Fever, unspecified

1.7

21.8

453

2751

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

9.7

21.8

G91.1

ICD-10 Finland

Obstructive hydrocephalus

11.5

21.7

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.7

21.5

261

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

15.4

21.5

N03AF01

ATC

carbamazepine; oral, rectal

2.5

21.2

172

711

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

21.1

835

5995

H34.1

ICD-10 Finland

Central retinal artery occlusion

9.1

21.0

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

12.0

21.0

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.7

20.9

37791

ICD-8 Finland

Other diseases of retina and optic nerve, Papilloedema. Stasis papillae

+∞

20.8

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

20.8

334

1857

F05

ICPC

Visual disturbance other

3.2

20.7

110

350

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

20.6

833

6004

J01EA01

ATC

trimethoprim; systemic

1.5

20.4

781

5558

A02BC01

ATC

omeprazole; systemic

1.5

20.4

802

5742

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

14.3

20.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

20.2

469

2934

H53.8

ICD-10 Finland

Other visual disturbances

5.4

20.0

112

N02AX02

ATC

tramadol; systemic, rectal

1.4

19.9

1189

9269

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

14.5

19.8

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

19.8

209

985

R4150

NOMESCO Finland

Neuropsychological rehabilitation

6.3

19.7

XCD20

NOMESCO Finland

Photoangiography of eye

4.4

19.7

167

H40.0

ICD-10 Finland

Glaucoma suspect

2.1

19.6

217

1044

102

Kela drug reimbursment

Diabetes insipidus

16.5

19.6

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

19.5

H54.1

ICD-10 Finland

Severe visual impairment, binocular

21.7

19.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

19.3

384

2297

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.6

19.2

146

583

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

19.1

348

2021

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.6

19.0

N28

ICPC

Limited function/disability (N)

4.6

18.9

146

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

11.4

18.9

3771A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic atrophy

+∞

18.8

H47

ICD-10 Finland

Other disorders of optic [2nd] nerve and visual pathways

+∞

18.8

114

Kela drug reimbursment

Glaucoma

2.1

18.7

219

1081

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

23.8

18.6

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

5.2

18.6

114

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

18.5

656

4572

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

10.7

18.4

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

17.8

260

1398

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

17.7

174

793

M03BX02

ATC

tizanidine; oral

1.4

17.7

1913

16422

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

17.6

456

2933

H02AB07

ATC

prednisone; oral

1.7

17.6

424

2677

R4120

NOMESCO Finland

Occupational therapy

2.1

17.6

211

1047

G04BD07

ATC

tolterodine; oral

2.4

17.5

154

665

H34.8

ICD-10 Finland

Other retinal vascular occlusions

3.8

17.5

197

A28

ICPC

Limited function/disability NOS

1.7

17.4

367

2231

G04BD08

ATC

solifenacin; oral

2.2

17.3

188

896

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.1

17.2

206

1024

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

17.2

176

819

A02BC03

ATC

lansoprazole; oral

1.5

17.1

812

6019

D35.30

ICD-10 Finland

Craniopharyngoma

31.6

17.0

L28

ICPC

Limited function/disability (L)

1.7

16.9

412

2608

WX110

NOMESCO Finland

Local anesthesy

1.4

16.8

2241

19819

H47.6

ICD-10 Finland

Disorders of visual cortex

+∞

16.7

N06AA09

ATC

amitriptyline; systemic

1.8

16.4

281

1598

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.4

16.4

230

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

16.3

1191

9532

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

5.7

16.3

N06AX16

ATC

venlafaxine; oral

1.6

16.1

445

2913

S01ED51

ATC

timolol, combinations; ophthalmic

2.1

16.0

186

912

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

7.2

16.0

N05BA09

ATC

clobazam; oral

6.2

15.9

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

15.8

530

3635

N06AX21

ATC

duloxetine; oral

1.7

15.7

323

1944

A06AD11

ATC

lactulose; oral

1.7

15.7

357

2216

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

4.1

15.6

152

G44.2

ICD-10 Finland

Tension-type headache

1.6

15.5

424

2766

H26.4

ICD-10 Finland

After-cataract

1.9

15.4

217

1151

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.6

15.3

195

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.8

15.2

105

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

9.2

15.2

WX882

NOMESCO Finland

High dependency care

2.7

15.1

102

381

H54.0

ICD-10 Finland

Blindness, binocular

20.1

15.1

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.8

15.1

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.2

15.0

246

H34.2

ICD-10 Finland

Other retinal artery occlusions

8.9

14.9

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

15.1

14.9

N03AX11

ATC

topiramate; oral

2.6

14.7

104

400

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

13.2

14.7

C03CA01

ATC

furosemide; systemic

1.5

14.5

653

4766

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

14.4

396

2583

J01DA01

ATC

[U] cefalexin; systemic

1.3

14.4

1939

16960

SPAT1216

SPAT

Assessment of functional ability

1.6

14.4

388

2523

S01EE01

ATC

latanoprost; ophthalmic

2.2

14.3

150

704

N06AB04

ATC

citalopram; systemic

1.5

14.3

628

4560

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

11.4

14.3

H40.11

ICD-10 Finland

Low pressure glaucoma

3.7

14.2

171

J01MA02

ATC

ciprofloxacin; systemic

1.4

14.2

1070

8564

H30.2

ICD-10 Finland

Posterior cyclitis

8.6

14.2

J01AA02

ATC

doxycycline; systemic

1.3

14.2

2387

21559

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

14.1

1104

8890

G04CA02

ATC

tamsulosin; oral

1.5

14.0

455

3093

N29

ICPC

Neurological sympt/complt other

3.2

14.0

237

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

14.0

609

4411

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.9

1235

10131

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

13.8

773

5873

A02BA02

ATC

ranitidine; systemic

1.5

13.6

515

3623

H20.1

ICD-10 Finland

Chronic iridocyclitis

4.0

13.6

138

36709

ICD-8 Finland

Inflammation of optic nerve and retina, Unspecified

+∞

13.5

XCW12

NOMESCO Finland

Assessment of colour vision

+∞

13.5

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.9

13.5

277

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

13.5

582

4206

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

13.5

150

726

N05BA01

ATC

diazepam; systemic, rectal

1.6

13.4

367

2389

CS2P4

NOMESCO Finland

Optic nerve head imaging

6.5

13.4

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

18.3

13.4

N03AX09

ATC

lamotrigine; oral

2.0

13.2

170

873

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.8

13.2

213

1190

C10AC01

ATC

colestyramine; oral

2.6

13.1

358

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

11.0

13.0

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

11.0

13.0

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.9

12.8

270

H03AA01

ATC

levothyroxine sodium; systemic

1.4

12.8

661

4941

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

12.8

681

5121

SPAT1153

SPAT

Removal of sutures

1.4

12.8

847

6613

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

12.7

220

1255

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.3

12.7

188

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

9.0

12.7

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

9.7

12.7

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

3.9

12.7

132

H01AC01

ATC

somatropin; parenteral

6.8

12.7

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.2

12.6

200

N99

ICPC

Neurological disease other

3.9

12.6

128

L01BB04

ATC

cladribine; systemic

70.1

12.6

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.3

12.6

195

H48.1*A69.2

ICD-10 Finland

Retrobulbar neuritis in Lyme disease

+∞

12.5

AAF10

NOMESCO Finland

Lumboperitoneal shunt

+∞

12.5

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

12.5

126

585

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

12.4

856

6725

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

12.3

165

861

N03AG01

ATC

valproic acid; systemic, rectal

1.8

12.3

196

1090

J01FF01

ATC

clindamycin; systemic

1.4

12.2

772

5973

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

12.2

135

650

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

12.1

258

1572

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.6

12.0

341

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

12.0

602

4475

J01CA08

ATC

pivmecillinam; oral

1.3

11.9

1224

10201

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

6.8

11.9

N30.0

ICD-10 Finland

Acute cystitis

1.5

11.8

401

2751

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.8

11.8

126

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

11.6

138

689

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

22.9

11.6

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.8

11.5

129

H47.5

ICD-10 Finland

Disorders of other visual pathways

+∞

11.5

M31.6

ICD-10 Finland

Other giant cell arteritis

13.6

11.4

SPAT1301

SPAT

No procedures

1.3

11.4

909

7285

4AA36

NOMESCO Finland

120.4

11.4

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

11.4

115

533

L04AA06

ATC

mycophenolic acid; systemic

3.0

11.3

220

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

11.3

117

547

R06.0

ICD-10 Finland

Dyspnoea

1.4

11.3

649

4931

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.2

11.3

178

RF120

NOMESCO Finland

3.8

11.3

121

J01DB01

ATC

cefalexin; oral

1.3

11.3

2620

24271

R3120

NOMESCO Finland

Training in mobility skills

15.1

11.3

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.6

11.3

321

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

8.3

11.3

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

11.3

1677

14648

WX892

NOMESCO Finland

Monitored bed care

1.8

11.2

209

1223

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

11.2

333

2210

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

11.2

353

2381

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

11.2

239

1459

CKC12

NOMESCO Finland

Photocoagulation of retina

2.2

11.1

118

558

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

25.1

11.1

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

11.1

863

6888

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

20.1

11.1

M79.6

ICD-10 Finland

Pain in limb

1.3

11.0

1001

8176

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

11.0

770

6046

183

Kela drug reimbursment

Lamotrigin and topiramate

3.8

10.9

120

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

2.2

10.9

106

484

ZXA00

NOMESCO Finland

Right side

1.4

10.8

692

5355

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

10.8

452

3237

S06.0

ICD-10 Finland

Concussion

1.6

10.8

286

1850

ZXC95

NOMESCO Finland

Use of surgical navigator

3.5

10.8

137

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

10.7

381

2637

G51.0

ICD-10 Finland

Bell palsy

2.6

10.7

303

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

10.7

105

481

H50.1

ICD-10 Finland

Divergent concomitant strabismus

4.3

10.6

N06AX11

ATC

mirtazapine; oral

1.3

10.6

888

7159

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

10.6

635

4856

N03AB02

ATC

phenytoin; systemic

4.2

10.6

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.8

10.5

170

950

M05BA04

ATC

alendronic acid; oral

1.8

10.5

183

1050

3774A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Other disorders of optic nerve

+∞

10.4

S01EC04

ATC

brinzolamide; ophthalmic

2.4

10.3

364

G03.9

ICD-10 Finland

Meningitis, unspecified

8.2

10.3

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

10.6

10.3

H52.0

ICD-10 Finland

Hypermetropia

2.8

10.2

238

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

10.2

263

1685

R01AD09

ATC

mometasone; nasal

1.3

10.2

1352

11585

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

10.1

1627

14273

Z50.1

ICD-10 Finland

Other physical therapy

1.9

10.1

145

778

R60.0

ICD-10 Finland

Localized oedema

1.6

10.0

269

1742

R13

ICD-10 Finland

Dysphagia

1.8

10.0

164

922

WX002

NOMESCO Finland

Sedation and analgesia

1.4

10.0

499

3694

H25.0

ICD-10 Finland

Senile incipient cataract

2.0

10.0

130

671

SPAT1262

SPAT

Handing over of treatment supplies

1.4

10.0

462

3373

RS222

NOMESCO Finland

3.2

10.0

157

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

9.9

1754

15548

SPAT1254

SPAT

Administration of medicine

1.5

9.9

394

2796

XA412

NOMESCO Finland

VEP

26.1

9.8

K02.1

ICD-10 Finland

Caries of dentine

1.3

9.8

1782

15839

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

9.8

962

7921

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

9.5

9.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

9.7

234

1476

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.9

9.7

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

2.7

9.7

245

W19

ICD-10 Finland

Unspecified fall

1.6

9.6

246

1575

RS221

NOMESCO Finland

2.9

9.6

201

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

3.8

9.6

104

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

9.5

280

R4190

NOMESCO Finland

Nutritional therapy

2.0

9.5

116

586

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.9

9.5

202

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

4.1

9.5

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

9.5

296

1990

S01ED01

ATC

timolol; ophthalmic

2.3

9.5

370

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

9.4

320

2190

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

9.4

483

3592

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

9.4

1301

11174

J01MA12

ATC

levofloxacin; systemic

1.4

9.4

460

3390

SPAT1263

SPAT

Sampling

1.3

9.4

1246

10650

H54.5

ICD-10 Finland

Severe visual impairment, monocular

6.2

9.4

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

9.3

253

1648

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

9.3

2236

20481

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

9.2

671

5281

ZXA05

NOMESCO Finland

Left side

1.3

9.2

624

4863

R11

ICD-10 Finland

Nausea and vomiting

1.6

9.2

227

1441

L02

ICPC

Back symptom/complaint

1.6

9.2

255

1669

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

9.1

183

1098

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

9.1

165

957

CA1ME

NOMESCO Finland

Ultrasound oculometry

4.8

9.1

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

9.1

253

1655

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

7.7

9.1

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

9.0

1458

12734

WW400

NOMESCO Finland

Plasmaferesis

10.0

9.0

RK110

NOMESCO Finland

3.9

9.0

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.2

9.0

N03AX18

ATC

lacosamide; systemic

4.5

8.9

6BA02

NOMESCO Finland

6.5

8.9

A04

ICPC

Weakness/tiredness general

1.5

8.9

357

2533

U05

ICPC

Urination problems other

2.0

8.8

111

570

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

6.8

8.8

H25.8

ICD-10 Finland

Other senile cataract

1.6

8.8

214

1356

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

3.7

8.7

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

8.7

263

1759

G82.2

ICD-10 Finland

Paraplegia, unspecified

6.6

8.6

P85

ICPC

Mental retardation

7.6

8.6

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

8.6

355

2534

G93.0

ICD-10 Finland

Cerebral cysts

6.1

8.6

S01EE05

ATC

tafluprost; ophthalmic

2.3

8.6

329

N01

ICPC

Headache

1.5

8.5

326

2288

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

4.4

8.5

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.7

8.5

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.7

8.5

199

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

8.5

204

1289

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

3.7

8.4

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

8.4

491

3729

N05BA04

ATC

oxazepam; oral

1.3

8.4

673

5366

C07AB07

ATC

bisoprolol; oral

1.3

8.4

1134

9682

3770A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Papilloedema

+∞

8.3

3772A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Other disorders of optic disk

+∞

8.3

H50.0

ICD-10 Finland

Convergent concomitant strabismus

3.9

8.3

S18

ICPC

Laceration/cut

1.3

8.3

1103

9391

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

8.2

1112

9485

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.4

8.2

272

U07

ICPC

Urine symptom/complaint other

1.7

8.2

150

875

WX290

NOMESCO Finland

Other blockade of nerve

1.2

8.2

1364

11911

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

8.2

473

3587

AA1AA

NOMESCO Finland

Head X-ray examination

4.2

8.2

H53.0

ICD-10 Finland

Amblyopia ex anopsia

3.4

8.2

109

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

8.1

306

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

8.1

230

1512

H40.9

ICD-10 Finland

Glaucoma, unspecified

3.0

8.1

148

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

33.4

8.1

J01CA04

ATC

amoxicillin; systemic

1.3

8.1

2615

24551

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

8.0

474

3606

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

10.0

8.0

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

5.3

8.0

M01AX17

ATC

nimesulide; oral

1.3

8.0

574

4505

RD210

NOMESCO Finland

2.3

8.0

295

WX872

NOMESCO Finland

Intensive care

1.9

7.9

114

616

N02AA05

ATC

oxycodone; systemic

1.5

7.9

317

2249

C08CA01

ATC

amlodipine; oral

1.3

7.9

796

6541

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

7.9

154

917

R02

ICPC

Shortness of breath/dyspnoea

1.5

7.8

299

2100

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

7.8

313

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

7.8

293

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.9

7.8

157

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

7.7

302

2135

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

7.7

1386

12181

2132

FHL

Ventricular operators sunt

45.1

7.7

34109

ICD-8 Finland

Other demyelinating diseases of central nervous system, Unspecified

45.1

7.7

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

15.0

7.7

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.2

7.7

120

UDM02

NOMESCO Finland

Sinoscopy

2.4

7.7

267

A02BC05

ATC

esomeprazole; systemic

1.2

7.7

1088

9316

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.7

1212

10502

J01MA06

ATC

norfloxacin; oral

1.4

7.6

351

2555

A01

ICPC

Pain general/multiple sites

1.6

7.6

192

1230

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

18.4

7.6

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.9

7.6

154

3313A

ICD-9 Finland

Other cerebral degenerations, Communicating hydrocephalus

25.1

7.6

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

7.5

290

2042

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

8.9

7.5

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

7.5

538

4215

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.2

7.5

117

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

7.5

837

6968

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

7.4

335

2430

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

7.4

1118

9627

S01EE03

ATC

bimatoprost; ophthalmic

2.6

7.4

204

2133

FHL

Suntin revisio

80.3

7.4

M54.5

ICD-10 Finland

Low back pain

1.3

7.4

902

7585

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

7.4

220

1464

R03CA02

ATC

ephedrine; oral

13.4

7.4

181

Kela drug reimbursment

Retigabine and vigabatrin

13.4

7.4

E23.2

ICD-10 Finland

Diabetes insipidus

7.6

7.4

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

7.3

443

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

7.3

719

5882

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

7.3

302

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

7.3

282

H52.2

ICD-10 Finland

Astigmatism

2.4

7.3

232

3773X

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS OPTICA ALIA SEU NUD]

+∞

7.3

RL140

NOMESCO Finland

6.8

7.3

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

7.3

114

635

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

7.2

518

PA2AD

NOMESCO Finland

CT angiography of brain

5.1

7.2

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

5.1

7.2

R06AE09

ATC

levocetirizine; oral

1.4

7.2

412

3114

Z43.5

ICD-10 Finland

Attention to cystostomy

6.2

7.2

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

15.8

7.2

R51

ICD-10 Finland

Headache

1.7

7.2

154

943

RF420

NOMESCO Finland

2.9

7.2

148

B01AB05

ATC

enoxaparin; parenteral

1.3

7.2

746

6148

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

30.1

7.1

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

30.1

7.1

EB1WA

NOMESCO Finland

4.8

7.1

ABD40

NOMESCO Finland

Implantation of spinal injection device

20.0

7.1

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

7.9

7.1

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

7.1

221

1489

H53

ICD-10 Finland

Visual disturbances

3.6

7.1

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

8.8

7.0

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.3

7.0

101

E0000UV

ATC

1.2

7.0

1128

9774

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.8

6.9

102

559

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

6.9

279

1986

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

6.9

312

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.2

6.9

N05BA12

ATC

alprazolam; oral

1.5

6.9

258

1809

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

7.5

6.9

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

4.6

6.9

J45

ICD-10 Finland

Asthma

1.5

6.9

252

1758

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

6.9

223

1516

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

8.3

6.8

R53

ICD-10 Finland

Malaise and fatigue

1.3

6.8

542

4313

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

10.9

6.8

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

10.9

6.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

6.8

1529

13695

M05BX04

ATC

denosumab; parenteral

1.8

6.8

106

590

N06AB10

ATC

escitalopram; oral

1.3

6.8

579

4651

D32.03

ICD-10 Finland

Benign meningioma in ventricles

9.3

6.8

G04BD11

ATC

fesoterodine; oral

2.1

6.8

342

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.6

6.8

XCH05

NOMESCO Finland

Eye pressure longterm registration

3.6

6.8

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

6.8

100

547

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

16.7

6.7

J01FA10

ATC

azithromycin; systemic

1.2

6.7

1784

16225

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

6.7

642

5234

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

6.6

171

1103

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.6

6.6

153

957

Z71.8

ICD-10 Finland

Other specified counselling

1.3

6.6

674

5535

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.9

6.6

502

NA7CM

NOMESCO Finland

Spine and spinal cord extensive MRI examination with 3 Tesla magnet

12.3

6.6

L17

ICPC

Foot/toe symptom/complaint

1.3

6.6

653

5349

R51.81

ICD-10 Finland

Facial pain NOS

2.1

6.5

320

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

3.3

6.5

N03AG04

ATC

vigabatrin; oral

10.0

6.5

WZA90

NOMESCO Finland

Other doctors statement

1.3

6.5

639

5223

H52.5

ICD-10 Finland

Disorders of accommodation

6.8

6.5

SPAT1104

SPAT

Monitoring of emergency patient

1.6

6.5

160

1020

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

6.5

194

1297

S97

ICPC

Chronic ulcer skin

1.7

6.5

118

691

H16.0

ICD-10 Finland

Corneal ulcer

1.7

6.5

120

708

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

6.5

1328

11767

H05.2

ICD-10 Finland

Exophthalmic conditions

6.2

6.5

N06AB06

ATC

sertraline; oral

1.4

6.4

301

2199

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

6.4

140

865

J01FA06

ATC

roxithromycin; oral

1.2

6.4

1113

9698

U13

ICPC

Bladder symptom/complaint other

2.0

6.4

392

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

7.4

6.4

AAF15

NOMESCO Finland

Ventriculoatrial shunt

7.4

6.4

CA1AD

NOMESCO Finland

Orbita CT

7.4

6.4

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

14.3

6.4

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

6.4

492

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

6.4

146

915

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.2

6.4

263

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

6.4

129

779

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

4.9

6.3

R4130

NOMESCO Finland

Speech therapy

2.2

6.3

276

G47.3

ICD-10 Finland

Sleep apnoea

1.3

6.3

501

3978

E66.8

ICD-10 Finland

Other obesity

1.6

6.3

147

925

WX704

NOMESCO Finland

Intubation

1.5

6.3

181

1196

M54.3

ICD-10 Finland

Sciatica

1.6

6.3

142

886

G91.8

ICD-10 Finland

Other hydrocephalus

11.0

6.3

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

11.0

6.3

R62.0

ICD-10 Finland

Delayed milestone

3.5

6.3

RT150

NOMESCO Finland

4.6

6.3

E22.80

ICD-10 Finland

Central precocious puberty

18.0

6.3

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.0

6.3

111

G37.0

ICD-10 Finland

Diffuse sclerosis

+∞

6.2

SPAT1234

SPAT

Support of social functional capacity

1.7

6.2

114

668

B01AC04

ATC

clopidogrel; oral

1.4

6.2

301

2212

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.5

6.2

185

1236

G45.3

ICD-10 Finland

Amaurosis fugax

2.6

6.2

164

Q85.01

ICD-10 Finland

Neurofibromatosis, type 2

26.7

6.2

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

26.7

6.2

G50.1

ICD-10 Finland

Atypical facial pain

2.4

6.2

208

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

6.2

2021

18670

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.8

6.2

134

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

2.4

6.2

201

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

6.2

158

1015

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.1

6.2

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.5

6.2

175

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

6.2

254

1813

S01EE04

ATC

travoprost; ophthalmic

2.4

6.2

202

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

6.2

110

643

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

6.1

746

6253

U02

ICPC

Urinary frequency/urgency

1.4

6.1

331

2482

J02AC01

ATC

fluconazole; systemic

1.2

6.1

1192

10493

E000001

ATC

1.3

6.1

561

4546

H26.2

ICD-10 Finland

Complicated cataract

2.8

6.1

129

Z94.0

ICD-10 Finland

Kidney transplant status

2.7

6.1

136

AA5PD

NOMESCO Finland

CT examination of brain pefusion

3.5

6.1

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

12.5

6.1

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

12.5

6.1

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

6.1

109

637

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

6.0

155

997

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

4.4

6.0

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

6.7

6.0

301

Kela drug reimbursment

Growth hormone

6.7

6.0

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

6.0

207

1427

WX140

NOMESCO Finland

Parabulbar anesthesy

1.8

6.0

496

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

6.0

413

3216

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

339

278

13.26

307.65

1.2

mg/l

45.4

37.0

0.88

273

234

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

332

267

13.50

307.65

1.1

1.0

mg/l

248.4

239.4

0.10

282

235

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

533

813

7.44

307.65

1.3

1.5

mg/l

487.1

495.5

0.07

505

772

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

292

90.11

307.65

1.2

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

334

263

13.80

307.65

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

158

82.30

297.69

1.2

1.1

—

(4027681)

279

216

13.84

294.46

1.3

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

447

657

7.56

294.36

1.4

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

176

42.82

293.60

3.2

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

456

716

7.08

282.33

1.5

1.7

e6/l

443.2

1502.7

1.39

372

578

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

456

717

7.07

281.95

1.4

1.6

e6/l

16.9

27.7

0.52

359

549

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

455

726

6.96

277.35

1.3

1.5

mmol/l

3.6

3.7

1.80

423

685

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

239

191

13.27

247.06

1.2

1.0

u/l

1.1

0.26

101

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

292

330

9.49

238.25

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

328

516

6.85

201.29

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

314

477

7.07

199.10

1.1

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

752

2399

3.65

196.24

3.3

2.7

g/l

9.7

10.5

7.02

686

2206

(3016018) Differential panel - Cerebral spinal fluid

238

339

7.41

159.59

1.4

1.8

—

(3023410) Appearance of Cerebral spinal fluid

220

343

6.74

135.47

1.5

2.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

635

2269

3.15

134.73

2.6

2.4

au/ml

30.0

22.6

0.62

149

(3011412) CD3 cells [#/volume] in Blood

210

316

6.97

133.70

3.5

2.3

e9/l

1.3

0.35

110

195

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

597

2072

3.22

132.96

1.4

1.3

au/ml

36.8

46.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

177

225

8.19

130.72

3.6

2.4

e9/l

0.2

0.50

152

190

(42870588) Differential panel, method unspecified - Blood

1788

10658

2.25

129.59

9.5

6.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

110

16.14

128.64

1.1

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

177

231

7.98

127.84

3.6

2.4

e6/l

476.0

577.1

1.21

150

189

(3006315) Basophils [#/volume] in Blood

2350

16026

2.18

116.94

10.3

5.9

e9/l

0.0

0.02

2118

13908

(3001604) Monocytes [#/volume] in Blood

2343

15975

2.17

116.44

10.3

5.9

e9/l

0.6

0.97

2114

13876

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

362

1016

3.83

111.39

1.8

1.6

iu/ml

0.3

6.3

0.50

201

(3019198) Lymphocytes [#/volume] in Blood

2381

16497

2.14

111.32

10.3

6.0

e9/l

1.8

2.0

3.45

2172

14639

(3013115) Eosinophils [#/volume] in Blood

2385

16596

2.13

109.43

10.6

6.2

e9/l

0.2

0.75

2160

14669

(3013650) Neutrophils [#/volume] in Blood by Automated count

2569

18443

2.16

107.87

12.3

8.9

e9/l

4.1

0.56

2331

16127

(3022096) Basophils/100 leukocytes in Blood

2160

14542

2.09

107.47

10.5

6.2

0.7

1.03

2080

13611

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

166

251

6.86

105.02

2.9

2.2

14.2

12.3

0.80

133

(3019069) Monocytes/100 leukocytes in Blood

2210

15084

2.08

104.97

10.7

6.4

8.8

8.4

6.43

2132

14181

(1175426) CD3 cells/100 lymphocytes in Blood

167

256

6.77

104.30

3.0

2.2

75.0

72.8

0.84

161

245

(3006504) Eosinophils/100 leukocytes in Blood

2196

14999

2.07

103.54

10.5

6.1

2.9

2.8

0.95

2114

14013

(3002030) Lymphocytes/100 leukocytes in Blood

2243

15589

2.04

98.94

10.5

6.1

26.6

28.8

19.18

2157

14604

(3018010) Neutrophils/100 leukocytes in Blood

2215

15370

2.02

97.60

10.2

6.0

58.7

56.7

14.28

2131

14442

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

395

1304

3.26

94.21

2.2

1.9

u/l

38.6

39.1

0.20

370

1181

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

156

249

6.48

93.67

1.3

mmol/l

1.7

2.0

2.56

141

234

(3000060) B lymphocytes [#/volume] in Blood

106

111

9.79

90.94

3.0

2.4

e6/l

254.5

233.0

0.06

(3006245) CD3-CD19+ cells/100 cells in Blood

119

145

8.43

90.84

3.4

2.5

6.9

11.0

2.34

111

136

(21494815) CD4 cells/100 lymphocytes in Specimen

158

270

6.06

88.61

2.5

2.3

49.2

44.1

0.75

(3024561) Albumin [Mass/volume] in Serum or Plasma

1885

12719

1.93

86.07

5.6

4.8

g/l

36.1

35.9

0.84

1766

11850

(3013826) Glucose [Moles/volume] in Serum or Plasma

2410

17751

1.94

83.31

5.9

4.7

mmol/l

6.5

6.6

1.07

2277

16430

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

117

159

7.56

81.44

1.1

miu/ml

1698.9

1530.2

0.64

117

159

(3028026) IgM [Mass/volume] in Serum or Plasma

473

1879

2.73

80.48

2.9

1.8

g/l

1.0

1.4

6.44

448

1733

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

137

225

6.27

79.93

3.9

2.4

e6/l

856.1

745.7

0.88

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

143

249

5.92

78.63

3.0

2.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1894

13077

1.87

77.90

2.7

2.3

nmol/l

82.1

75.9

13.72

1755

11934

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

103

141

7.48

71.22

3.2

2.3

26.7

28.1

0.42

135

(3018677) aPTT in Platelet poor plasma by Coagulation assay

821

4459

2.07

67.15

2.4

2.3

29.8

0.09

790

4316

(3030467) Casts [#/volume] in Urine by Automated count

1309

8328

1.86

67.13

4.6

3.1

e6/l

0.2

0.4

2.18

1050

6272

(3010503) CD19 cells [#/volume] in Blood

112

179

6.41

67.09

3.5

2.2

e9/l

0.3

0.14

112

174

(3018095) Leukocytes [#/volume] in Urine

1602

10883

1.80

65.99

5.6

3.6

e6/l

74.6

92.9

0.50

1194

7560

(3002582) Erythrocytes [#/volume] in Urine

1393

9093

1.83

65.36

4.9

3.2

e6/l

80.5

85.7

0.04

1130

6958

(36304419) Bacteria [Presence] in Urine

1285

8216

1.84

64.26

4.5

3.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2743

21933

1.85

63.97

6.6

4.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2642

20894

1.82

63.78

6.9

4.2

e6/l

286.8

1642.6

2.27

273

(3000850) Epithelial cells [#/volume] in Urine

1053

6333

1.91

63.75

3.9

2.5

e6/l

4.8

6.5

5.86

961

5537

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

101

154

6.71

63.29

1.7

—

(3026782) Osmolality of Urine

993

5896

1.92

62.29

3.8

2.7

mosm/kgh2o

549.0

549.2

0.01

889

5028

(3026008) Bacteria identified in Urine by Culture

1373

9031

1.80

62.06

3.9

2.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

8.91

61.78

4.0

2.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1994

14646

1.74

61.02

8.9

6.6

mmol/l

1.2

0.36

1698

12442

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1314

8643

1.79

58.64

2.4

2.1

u/l

165.0

220.3

1.69

1241

8143

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

156

6.35

57.74

1.3

59.0

68.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2863

23509

1.82

57.42

8.9

7.2

u/l

78.3

77.5

0.37

2711

22182

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

133

290

4.71

56.79

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1824

13269

1.71

56.09

8.3

6.1

mmol/l

1.2

1.04

1683

12071

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2064

15538

1.70

55.72

6.6

6.1

umol/l

10.6

11.5

2.23

1958

14698

(3035350) Ketones [Presence] in Urine by Test strip

2052

15580

1.67

52.27

5.2

3.5

estimate

0.0

0.80

439

2915

(3021589) Normoblasts [#/volume] in Blood

1913

14283

1.67

51.83

13.3

9.0

e9/l

0.0

0.03

1612

11655

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

234

813

3.00

50.49

2.2

2.0

mg/l

10.1

11.1

1.15

220

756

(3009261) Glucose [Presence] in Urine by Test strip

2056

15765

1.64

49.16

5.2

3.5

estimate

0.0

1.32

444

2895

(3021601) Nitrite [Presence] in Urine by Test strip

2035

15610

1.64

48.19

6.9

4.7

estimate

0.0

0.40

443

2997

(3032080) INR in Blood by Coagulation assay

1560

11295

1.64

45.88

8.9

8.4

inr

1.2

0.35

439

3363

(3002179) Metamyelocytes/100 leukocytes in Blood

459

2325

2.10

43.84

4.9

3.9

0.8

0.6

0.36

116

502

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

9.09

43.37

1.1

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

486

2549

2.04

42.17

5.2

4.2

0.8

0.09

148

697

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

812

5070

1.76

40.90

3.9

2.7

e6/l

1.0

1.2

1.00

478

2862

(3021440) Promyelocytes/100 leukocytes in Blood

464

2427

2.04

40.48

5.3

4.3

0.1

0.01

141

643

(21494814) CD8 cells/100 lymphocytes in Specimen

114

6.14

40.01

2.3

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

1128

7749

1.64

39.58

5.0

4.0

94.3

91.8

3.02

1107

7545

(3025159) Blasts/100 leukocytes in Blood

442

2293

2.05

39.40

5.3

4.3

0.0

0.4

0.92

124

540

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

117

5.99

38.98

1.2

1.1

ng/l

101.2

249.4

0.56

(3019550) Sodium [Moles/volume] in Serum or Plasma

3532

32090

2.09

38.96

20.5

14.4

mmol/l

139.6

0.02

3464

31262

(3013707) Erythrocyte sedimentation rate by Westergren method

2750

23335

1.61

38.08

4.8

4.0

mm/h

12.0

11.2

2.26

2573

21695

(3036481) Cortisol [Moles/volume] in Serum or Plasma

548

3099

1.89

37.94

2.9

2.1

nmol/l

377.5

369.7

0.19

513

2856

(3023103) Potassium [Moles/volume] in Serum or Plasma

3536

32194

2.08

37.91

20.6

14.5

mmol/l

3.9

1.40

3458

31293

(3018418) pH of Serum or Plasma

1212

8564

1.60

37.50

5.4

3.9

7.4

2.08

237

1625

(40758558) Short blood count panel - Blood

1156

8095

1.61

37.05

8.9

6.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

238

980

2.52

36.89

1.6

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1057

7278

1.62

36.15

4.7

3.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3527

32214

2.01

35.43

19.1

13.0

mg/l

22.6

22.5

0.12

2890

25185

(3023368) Bacteria identified in Blood by Culture

1087

7639

1.59

33.71

5.4

4.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

630

3846

1.76

33.67

7.5

6.1

mmol/l

1.1

0.15

591

3584

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

743

4768

1.69

33.10

4.1

2.9

e6/l

3.4

2.8

0.79

407

2576

(3009445) Proteinase 3 Ab [Units/volume] in Serum

270

1235

2.27

33.04

1.8

1.5

u/ml

37.6

15.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1352

10071

1.52

31.92

3.1

3.3

mmol/l

2.3

2.4

0.46

1206

8918

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

5.63

31.89

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

403

2179

1.95

31.66

2.2

2.7

g/l

66.5

66.7

0.17

377

2014

(3021879) Hepatitis B virus core Ab [Presence] in Serum

472

2719

1.84

30.45

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

715

4635

1.66

30.38

1.9

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

188

4.27

30.28

3.6

2.8

49.2

41.2

2.18

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

223

985

2.34

29.58

1.6

titre

378.7

284.0

0.21

(3020779) Urea [Moles/volume] in Serum or Plasma

446

2552

1.84

29.35

9.5

7.9

mmol/l

8.9

9.1

0.15

427

2441

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1409

10731

1.49

29.23

3.8

3.3

ng/l

45.5

49.6

0.14

926

6589

(3012095) Magnesium [Moles/volume] in Serum or Plasma

720

4732

1.64

28.83

4.1

3.6

mmol/l

0.8

0.24

683

4436

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

5.64

28.31

1.2

22.8

16.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

466

2737

1.80

28.09

6.2

4.3

kpa

5.8

0.25

460

2652

(3002032) Base excess in Venous blood by calculation

464

2723

1.80

28.05

6.2

4.4

mmol/l

1.7

1.8

0.22

376

2175

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

159

616

2.65

27.91

4.2

3.7

59.1

56.9

1.16

159

616

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

4.09

27.25

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

652

4241

1.65

27.04

1.7

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

182

780

2.40

25.84

1.5

1.4

iu/ml

14.3

13.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1013

7403

1.50

24.91

7.7

4.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

181

3.98

24.88

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1348

10448

1.44

24.39

4.0

3.2

u/l

33.3

32.5

0.14

1281

9939

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3613

33925

1.91

23.83

14.4

9.7

u/l

26.3

25.9

0.56

3527

32830

(3008295) Osmolality of Serum or Plasma

313

3.15

23.81

1.5

mosm/kgh2o

287.1

281.9

1.42

239

(3003396) Base excess in Arterial blood by calculation

494

3113

1.67

22.92

8.3

7.8

mmol/l

0.9

1.0

0.32

356

2424

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

494

3119

1.67

22.74

8.3

7.8

kpa

5.0

5.1

1.57

466

2979

(3027801) Oxygen [Partial pressure] in Arterial blood

494

3120

1.67

22.71

8.3

7.7

kpa

13.3

12.6

1.47

465

2980

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1482

11822

1.41

22.30

2.0

1.9

pmol/l

97.5

96.3

0.40

807

6230

(3007164) IgA [Mass/volume] in Serum or Plasma

936

6875

1.48

22.00

1.9

1.4

g/l

2.1

2.3

4.16

604

4234

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

499

3200

1.64

21.55

1.9

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

538

3524

1.61

21.31

8.5

7.1

mmol/l

105.4

104.5

4.54

529

3447

(3037522) Nuclear Ab [Titer] in Serum

657

4523

1.54

20.96

1.4

titre

443.8

535.5

1.12

147

916

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

491

3182

1.62

20.26

1.9

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

555

3709

1.58

20.13

2.1

1.7

—

(3000991) Gas panel - Venous blood

404

2500

1.69

19.96

11.1

8.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3219

29615

1.50

19.81

5.4

4.8

mu/l

1.8

2.1

1.67

2996

27495

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1206

9448

1.40

19.50

3.1

2.5

u/l

57.6

57.4

0.02

1122

8733

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2469

21698

1.38

19.47

4.0

3.0

u/l

48.5

43.9

1.61

2347

20451

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

323

1893

1.77

19.39

2.6

2.2

u/l

3885.2

5574.9

0.62

753

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

842

6191

1.46

19.33

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

584

3984

1.55

19.29

3.1

2.6

21.5

23.3

2.39

494

3452

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

276

1545

1.85

19.28

7.2

4.8

mmol/l

24.0

0.17

259

1412

(3002173) Hemoglobin [Mass/volume] in Arterial blood

409

2567

1.66

19.12

9.1

8.5

g/l

121.0

122.3

0.60

391

2469

(3024980) IgG subclass 4 [Mass/volume] in Serum

125

521

2.45

18.93

1.5

1.7

g/l

0.5

0.7

2.00

398

(3029937) Albumin [Presence] in Urine by Test strip

1081

8346

1.41

18.91

6.3

3.8

estimate

0.0

1.49

437

2905

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1481

12059

1.37

18.74

5.7

3.6

—

(3016502) Oxygen saturation in Arterial blood

430

2772

1.62

18.04

8.9

8.3

96.5

95.7

2.95

408

2673

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3189

29434

1.46

17.84

16.3

11.7

ml/min/173m2

86.8

85.3

3.09

2700

24151

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

126

543

2.36

17.74

1.3

1.2

titre

125.7

252.3

—

(40761511) CBC panel - Blood by Automated count

3562

33687

1.68

17.71

17.1

12.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

656

4689

1.48

17.19

3.0

2.5

umol/l

12.5

13.6

3.71

611

4373

(3004789) Transferrin [Mass/volume] in Serum or Plasma

611

4308

1.50

17.14

3.0

2.5

g/l

2.3

2.4

0.79

568

4018

(3004588) Protein electrophoresis panel - Serum or Plasma

296

1756

1.74

17.00

2.2

2.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

930

7120

1.40

16.74

2.0

1.8

mg/l

1.3

1.1

0.51

703

5327

(3014111) Lactate [Moles/volume] in Serum or Plasma

389

2500

1.62

16.48

9.6

7.4

mmol/l

1.3

0.07

378

2404

(3021387) Prolactin [Units/volume] in Serum or Plasma

265

1548

1.76

16.06

2.1

1.6

mu/l

338.4

299.5

1.11

243

1394

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2791

25326

1.36

15.98

4.6

4.1

pmol/l

14.7

14.6

1.87

2577

23297

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.26

15.95

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.26

15.95

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

115

3.95

15.81

1.1

1.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

316

1948

1.68

15.76

5.2

4.5

kpa

5.2

5.1

0.70

296

1810

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

305

1865

1.69

15.68

5.3

4.5

mmol/l

1.5

1.6

0.31

223

1374

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

252

1465

1.77

15.53

10.5

10.8

—

(3009343) pH of Capillary blood

312

1927

1.67

15.45

5.2

4.5

7.4

0.01

210

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

467

3178

1.53

15.40

3.9

4.3

u/l

237.9

245.8

0.52

445

3018

(3019309) Folate [Moles/volume] in Red Blood Cells

697

5138

1.43

15.39

1.8

1.7

nmol/l

1184.7

1169.7

0.18

542

3923

(3008757) Leukocyte morphology finding [Identifier] in Blood

316

2.66

15.22

4.3

3.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

229

1306

1.80

15.06

2.4

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

275

1661

1.71

14.80

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

855

6571

1.39

14.78

1.6

1.5

nmol/l

20.1

20.6

0.33

738

5689

(3002385) Erythrocyte distribution width [Ratio]

2971

27336

1.37

14.77

23.7

15.7

13.7

13.6

1.66

2926

26752

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

101

3.99

14.31

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

201

1123

1.83

14.15

1.9

1.4

u/l

9.9

0.00

159

907

(3004119) Hemoglobin [Mass/volume] in Venous blood

274

1674

1.69

14.13

5.6

3.6

g/l

129.6

129.7

0.03

269

1628

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

186

1015

1.87

14.11

2.0

1.7

g/l

0.2

0.00

177

955

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

190

1048

1.85

13.94

2.0

1.7

g/l

1.2

0.16

182

985

(40761536) Microorganisms panel - Urine sediment

409

2767

1.53

13.81

6.1

3.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.03

13.78

2.4

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

3.93

13.67

1.3

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

109

498

2.22

13.47

4.1

3.4

u/ml

283.7

1555.5

—

(3042936) Bacteria identified in Isolate by Culture

584

4264

1.43

13.44

2.4

2.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

174

945

1.88

13.40

2.4

ug/l

520.4

493.4

0.05

163

878

(3028192) IgG subclass 2 [Mass/volume] in Serum

325

2.52

13.40

1.5

1.4

g/l

2.8

0.09

228

(3024139) IgG subclass 3 [Mass/volume] in Serum

325

2.52

13.40

1.5

1.4

g/l

0.4

0.26

226

(3027135) IgG subclass 1 [Mass/volume] in Serum

326

2.52

13.32

1.5

1.4

g/l

6.0

6.6

0.74

229

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

196

2.99

13.30

2.0

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

502

3569

1.47

13.30

3.1

2.8

umol/l

6.8

7.4

0.32

424

3091

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

992

7923

1.34

13.18

2.4

2.2

mg/l

3.1

2.9

2.75

870

6801

(4062490)

328

2.50

13.15

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

949

7542

1.34

13.01

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

929

7363

1.34

12.97

3.1

ng/l

1569.1

1320.8

0.83

775

6224

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.92

12.96

1.2

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

644

2.04

12.71

6.8

5.8

iu/ml

1002.3

580.1

0.41

(3007930) Methemoglobin/Hemoglobin.total in Blood

188

1068

1.80

12.55

5.6

0.9

0.04

174

995

(3035637) Corticotropin [Mass/volume] in Plasma

429

2.27

12.53

1.7

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

189

1078

1.79

12.46

5.6

5.5

1.6

1.7

0.10

174

1002

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

322

2122

1.56

12.21

1.8

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

257

2.64

12.18

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

265

1670

1.63

12.12

7.6

7.4

mmol/l

23.9

24.5

1.54

242

1552

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

110

530

2.11

11.93

2.1

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

445

2.21

11.91

3.3

3.4

1.3

1.5

0.21

350

(3036489) Thrombin time

210

1251

1.72

11.91

2.5

21.2

21.4

0.29

191

1083

(3052851) Hemolysis interference index of Serum or Plasma

164

911

1.84

11.80

3.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

179

1022

1.79

11.77

3.9

3.0

g/l

3.4

3.5

0.58

173

964

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

136

3.26

11.75

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

236

1456

1.66

11.74

10.8

10.0

mmol/l

24.2

0.18

225

1375

(3013512) EKG study

994

8052

1.31

11.74

3.9

3.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

447

3186

1.46

11.63

3.4

2.7

1.7

1.8

0.24

399

2850

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

5.25

11.53

1.3

1.2

62.0

45.7

—

(3022313) Gas panel - Capillary blood

233

1445

1.65

11.37

5.6

4.7

—

(3019060) Gas panel - Arterial blood

271

1745

1.59

11.35

5.3

5.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

143

772

1.88

11.27

1.4

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

212

1288

1.68

11.19

4.3

3.5

mmol/l

24.5

25.2

1.98

207

1243

(3041096) Erythrocytes [Presence] in Urine by Automated

1055

8668

1.30

11.12

5.0

3.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

110

548

2.04

10.95

1.6

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

211

1288

1.67

10.95

6.1

5.0

mmol/l

24.7

0.05

195

1210

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

125

3.22

10.53

1.1

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.56

10.46

2.3

2.6

umol/l

27.6

29.8

0.41

(3028626) Oxygen [Partial pressure] in Capillary blood

148

829

1.82

10.40

6.3

5.1

kpa

9.0

8.6

1.75

139

768

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

320

2184

1.51

10.33

4.9

4.1

ng/l

99.6

84.6

1.21

284

1915

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

176

1040

1.73

10.31

2.1

1.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

264

1731

1.56

10.24

1.6

1.5

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

7.80

10.14

1.1

1.3

20.1

43.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

409

2942

1.44

10.10

3.5

2.4

u/l

32.7

54.8

0.76

346

2532

(3023183) Ammonium ion [Moles/volume] in Plasma

119

628

1.92

10.08

3.1

2.9

umol/l

32.0

34.9

0.87

102

543

(3027315) Oxygen [Partial pressure] in Blood

122

650

1.91

10.05

4.6

3.9

kpa

8.7

0.04

117

641

(3012501) Base excess in Blood by calculation

122

650

1.91

10.05

4.6

3.9

mmol/l

2.3

2.5

0.33

423

(3013290) Carbon dioxide [Partial pressure] in Blood

122

651

1.90

10.00

4.6

3.9

kpa

5.0

0.36

117

643

(3023520) Reticulocytes [#/volume] in Blood

333

2309

1.48

9.95

2.7

2.6

e9/l

70.2

70.4

0.02

251

1730

(3039000) Anion gap in Blood

113

593

1.93

9.75

7.0

8.0

mmol/l

11.9

11.3

0.82

525

(3010813) Leukocytes [#/volume] in Blood

3714

36065

1.65

9.73

28.8

19.0

e9/l

6.8

6.7

1.11

3637

35137

(3024731) MCV [Entitic volume]

3713

36054

1.65

9.71

28.7

18.9

90.8

90.5

2.72

3674

35608

(3018572) Chloride [Moles/volume] in Blood

113

594

1.93

9.70

7.0

8.0

mmol/l

105.1

105.4

0.26

526

(3044889) 12 lead EKG panel

2311

21033

1.24

9.69

3.8

3.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

153

885

1.76

9.68

5.2

3.7

u/ml

0.3

0.4

0.07

502

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

697

5502

1.33

9.67

3.9

3.5

ng/l

355.8

617.8

0.61

465

3941

(3035941) MCH [Entitic mass]

3713

36057

1.65

9.67

28.7

18.9

30.2

0.00

3674

35607

(3007461) Platelets [#/volume] in Blood

3711

36034

1.64

9.65

28.8

19.0

e9/l

258.8

256.6

1.24

3644

35186

(3026361) Erythrocytes [#/volume] in Blood

3713

36062

1.64

9.60

28.8

19.0

e12/l

4.5

2.52

3642

35137

(1616796) Gas panel - Central venous blood

117

625

1.90

9.58

3.8

3.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

3713

36074

1.64

9.43

29.0

19.1

g/l

134.1

135.1

3.93

3673

35619

(3047181) Lactate [Moles/volume] in Blood

148

856

1.76

9.38

6.1

6.7

mmol/l

1.4

1.3

0.44

128

738

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

149

864

1.75

9.36

3.0

2.8

—

(3010421) pH of Blood

137

776

1.79

9.32

4.7

3.8

7.4

1.95

118

642

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

334

2348

1.46

9.31

5.1

3.6

mmol/l

1.2

1.27

299

2037

(40761535) Cells panel - Urine sediment

340

2403

1.45

9.22

5.4

3.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

468

3507

1.38

9.11

8.3

6.3

—

(3019150) Specific gravity of Urine by Refractometry

830

6764

1.29

9.04

5.8

3.8

kg/l

1.0

0.68

108

1004

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

185

1149

1.64

9.02

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

115

627

1.86

8.87

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

115

627

1.86

8.87

1.4

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

203

1297

1.60

8.83

1.3

u/ml

2.6

0.7

—

114

(3044640) Blood type and Crossmatch panel - Blood

1173

9990

1.25

8.81

2.7

2.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

193

1226

1.60

8.61

1.8

1.9

g/l

1.4

1.5

0.35

165

1072

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1701

15103

1.22

8.58

3.3

2.9

ug/l

115.8

103.9

1.46

1584

14118

(3017446) Testosterone [Moles/volume] in Serum or Plasma

289

2011

1.47

8.49

3.0

2.2

nmol/l

11.4

12.1

0.76

258

1767

(3013005) Retinol [Moles/volume] in Serum or Plasma

154

2.75

8.43

2.2

2.0

umol/l

1.9

1.8

0.07

144

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

142

841

1.71

8.31

1.8

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

436

1.99

8.25

2.3

2.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

118

664

1.80

8.25

1.7

1.5

u/ml

106.8

112.1

0.23

129

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

910

7575

1.26

8.24

2.6

2.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

520

1.91

8.24

1.3

u/ml

3.6

4.9

0.55

231

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

317

2262

1.44

8.17

2.4

2.3

ug/l

5.3

6.9

1.60

272

1997

(3026493) Urate [Moles/volume] in Serum or Plasma

927

7748

1.26

8.09

2.9

2.6

umol/l

1285.2

4401.6

4.66

810

6790

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.48

8.08

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

464

1.94

7.90

1.2

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.87

7.88

2.5

4.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.63

7.87

2.1

1.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

155

2.66

7.79

3.0

2.4

umol/l

59.9

53.1

0.65

128

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

127

2.85

7.78

1.5

mu/l

1150.6

400.4

0.55

122

(3012516) Albumin [Mass/volume] in Urine

945

7955

1.25

7.69

4.0

3.3

mg/l

703.3

339.0

1.04

607

5043

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

378

2811

1.38

7.69

2.4

2.3

g/l

0.2

0.63

359

2635

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.33

7.67

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.33

7.67

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.44

7.66

1.1

1.3

nmol/l

112.5

116.7

0.06

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

123

718

1.74

7.61

2.5

2.4

g/l

0.0

0.00

113

669

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

408

1.98

7.58

1.1

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

122

712

1.74

7.56

2.5

2.4

g/l

0.0

0.00

113

668

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.10

7.53

1.2

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

958

1.63

7.52

2.2

2.5

g/l

3.3

3.1

1.19

117

760

(3009508) Creatinine [Moles/volume] in Urine

1050

8962

1.24

7.50

4.0

3.3

mmol/l

7.3

7.6

1.44

906

7620

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

169

1079

1.59

7.42

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

183

1192

1.56

7.38

2.0

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

131

2.76

7.37

1.5

75.8

72.7

0.94

126

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1670

14949

1.21

7.36

4.3

4.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

160

1012

1.61

7.31

2.2

2.5

g/l

3.6

3.8

0.73

117

738

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

651

5272

1.28

7.31

2.9

mmol/l

2.4

0.10

572

4631

(3000494) Fungus identified in Specimen by Culture

473

3671

1.33

7.29

1.7

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

160

1013

1.60

7.28

2.2

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

160

1013

1.60

7.28

2.2

2.5

g/l

7.6

7.3

1.20

119

777

(3028433) Virus identified in Specimen by Culture

110

2.92

7.26

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

299

2.13

7.26

3.3

3.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

129

774

1.69

7.25

2.4

g/l

0.0

0.04

119

724

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

150

936

1.63

7.25

2.3

2.5

g/l

9.9

10.4

0.86

122

808

(3020891) Body temperature

168

1078

1.58

7.23

6.0

4.7

—

(3042631) Mycobacterium sp identified in Specimen

340

2.05

7.21

4.9

2.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.94

7.15

1.2

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

980

8342

1.23

7.13

4.8

4.0

mg/mmol

14.6

9.2

1.75

638

5316

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

7.71

7.12

1.1

1.3

1.6

0.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

112

650

1.74

7.10

1.4

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

323

2.06

7.03

1.9

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

121

720

1.70

7.02

1.7

1.5

—

(3051651) Icteric interference index of Serum or Plasma

188

2.41

7.00

3.5

3.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2952

27956

1.23

6.98

5.8

5.2

mmol/mol

39.5

39.0

2.17

2762

26070

(40767503) Oxygen content in Capillary blood by calculation

103

589

1.77

6.88

2.8

2.4

16.4

16.3

0.12

291

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

148

937

1.60

6.76

1.3

1.2

u/ml

14.7

46.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

162

1049

1.57

6.73

2.2

2.0

ug/l

1.4

2.1

0.63

138

934

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.46

6.70

1.3

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.70

6.68

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

295

2156

1.40

6.67

3.0

3.4

pmol/l

4.5

0.02

267

1926

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

130

803

1.64

6.57

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

107

630

1.72

6.48

1.6

1.4

u/l

19.8

24.4

1.01

524

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

214

2.26

6.48

1.3

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

129

799

1.64

6.46

2.4

2.3

g/l

37.9

38.0

0.05

112

699

(3024928) Oxygen saturation in Venous blood

105

618

1.72

6.37

7.3

3.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

530

1.77

6.32

1.4

1.2

u/ml

3.3

4.6

0.55

186

(3036525) Urea [Moles/time] in 24 hour Urine

6.68

6.31

1.9

3.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.22

6.28

1.1

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

392

3026

1.33

6.26

3.8

3.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

211

2.24

6.25

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

270

3644

0.72

6.19

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

137

872

1.59

6.16

2.4

2.5

g/l

0.3

1.0

4.10

120

775

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

123

763

1.63

6.14

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

118

725

1.65

6.12

1.3

u/ml

246.6

258.6

0.22

434

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

137

875

1.59

6.07

5.8

5.5

mg/l

1.5

1.4

0.75

123

820

(3003181) Sodium [Moles/volume] in Urine

472

1.80

6.00

2.0

1.4

mmol/l

71.7

64.5

0.69

391

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.46

6.00

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

159

1062

1.52

5.79

3.9

3.5

g/l

0.3

0.06

460

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.66

5.73

1.5

mg/l

1.3

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.47

5.72

6.1

6.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.91

5.71

1.3

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

913

7878

1.21

5.62

1.3

u/ml

1.9

1.6

0.36

226

2106

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.85

5.50

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

405

1.82

5.47

1.8

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3130

30024

1.22

5.47

4.5

4.1

mmol/l

5.9

5.8

0.65

2875

27647

(3042733) HLA Ab [Presence] in Serum

106

2.65

5.40

5.5

4.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

728

6169

1.22

5.37

1.7

1.6

pmol/l

22660534.1

33846287.6

0.28

609

5203

(3017354) Segmented neutrophils/100 leukocytes in Blood

273

1.99

5.35

2.7

3.2

53.2

55.4

0.25

177

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.34

5.29

1.2

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

148

994

1.51

5.29

1.2

—

(3011648) Oxygen content in Venous blood

247

2.04

5.29

5.1

4.4

13.0

11.2

2.62

247

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

114

722

1.60

5.28

1.8

1.6

—

(40768446) Kidney Pathology biopsy report

125

2.49

5.28

2.0

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

113

715

1.60

5.26

3.2

3.4

mmol/l

23.8

24.7

1.26

626

(3021901) Oxygen saturation in Capillary blood

492

1.72

5.26

2.9

2.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

367

1.84

5.25

8.4

6.8

mg/l

11.0

11.5

0.50

343

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

679

5727

1.22

5.23

1.3

iu/ml

28.6

30.2

0.11

161

1764

(3018405) Lactate [Moles/volume] in Arterial blood

145

972

1.51

5.23

4.6

4.1

mmol/l

1.3

1.4

0.30

140

958

(3048929) Epstein Barr virus Ab [Presence] in Serum

177

1238

1.45

5.17

1.3

—

(3016038) Potassium [Moles/volume] in Urine

177

2.22

5.12

1.7

1.3

mmol/l

40.7

35.3

0.57

163

(3017817) Protein [Mass] in Urine collected for unspecified duration

257

2.00

5.12

2.1

2.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

204

2.12

5.07

1.8

2.8

98.7

96.4

0.17

191

(40768443) Skin Pathology biopsy report

181

1277

1.44

5.06

1.3

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.18

5.03

1.9

1.4

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.46

5.03

1.4

1.5

mg/l

1.7

1.9

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.46

5.03

1.4

1.5

mg/l

0.6

1.2

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.46

5.03

1.4

1.5

mg/l

1.7

2.2

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.46

5.03

1.4

1.5

mg/l

3.5

5.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.46

5.03

1.4

1.5

mg/l

1.4

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.46

5.03

1.4

1.5

mg/l

3.1

3.5

—

(4146454)

273

1.95

5.01

3.1

2.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

239

2.02

4.99

1.2

1.3

titre

42.5

211.7

—

(3017732) Neutrophils [#/volume] in Blood

295

2262

1.33

4.97

2.5

2.8

e9/l

4.4

4.1

1.11

249

1835

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

111

710

1.58

4.96

1.8

1.6

—

(3023419) Bacteria identified in Sputum by Culture

339

1.84

4.91

3.4

2.8

—

(3004616) Nuclear Ab [Presence] in Serum

384

1.78

4.85

1.3

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

228

2.03

4.85

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

147

2104

0.69

4.77

1.9

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.85

4.65

1.5

2.1

umol/l

19.6

16.3

0.47

(3048689) Calprotectin [Mass/mass] in Stool

518

4302

1.24

4.61

2.4

ug/g

138.0

114.0

0.59

409

3405

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.34

4.60

1.4

2.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

213

2.03

4.56

1.8

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

624

1.59

4.50

4.4

2.3

nmol/l

0.9

0.8

0.79

529

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

128

865

1.50

4.49

1.3

u/ml

10.1

8.4

0.09

141

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.54

4.46

1.6

1.4

—

(4268621)

365

1.77

4.45

2.5

2.3

—

(3011985) Renin [Units/volume] in Plasma

380

1.75

4.44

1.5

mu/l

57.1

51.5

0.16

340

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.01

4.43

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

1420

12925

1.16

4.40

2.2

2.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.83

4.38

1.4

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.72

4.36

1.2

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

288

2248

1.30

4.30

1.4

1.3

u/ml

369.4

195.3

0.89

264

2083

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

546

1.61

4.26

4.5

2.9

—

(3022217) INR in Platelet poor plasma by Coagulation assay

417

3412

1.25

4.25

26.4

22.3

inr

1.2

1.3

1.26

503

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

125

851

1.48

4.25

1.3

u/ml

2.6

6.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

128

876

1.48

4.24

1.3

titre

62.5

92.6

1.42

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.63

4.22

1.1

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

464

1.65

4.16

5.0

5.4

umol/l

416.1

370.7

1.85

405

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

116

784

1.49

4.10

4.0

3.5

mg/l

33.0

72.4

1.42

642

(1761868) Lipid panel - Serum or Plasma

1055

11737

0.86

4.10

2.8

2.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

116

2.34

4.08

1.5

1.3

85.5

88.8

0.15

(3006184) Hemoglobin [Mass/volume] in Capillary blood

632

1.55

4.07

2.5

2.2

g/l

129.6

0.01

465

(3020961) Endomysium IgA Ab [Titer] in Serum

229

1746

1.33

4.06

1.1

titre

65.8

143.4

—

(4035726)

323

2580

1.27

4.05

1.6

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

113

763

1.50

4.02

4.0

3.5

ratio

1.3

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

325

2603

1.27

3.99

1.3

1.2

iu/ml

162.5

165.9

0.05

120

964

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

260

1.86

3.98

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

260

1.86

3.98

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

260

1.86

3.98

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

260

1.86

3.98

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

260

1.86

3.98

1.3

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

349

1.73

3.94

1.7

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

261

1.85

3.94

1.3

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

115

784

1.48

3.91

4.0

3.5

mg/l

81.1

60.6

0.23

643

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

519

1.59

3.91

1.9

1.7

—

(3019225) pH of Specimen

351

2854

1.25

3.80

4.9

4.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

120

2.26

3.80

1.4

1.1

88.6

90.2

0.11

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

133

2.19

3.79

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

376

1.69

3.79

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

167

2.05

3.74

1.3

1.4

nmol/l

143.3

131.5

0.71

167

(3043409) Potassium [Moles/volume] in Arterial blood

119

825

1.46

3.74

4.8

4.3

mmol/l

3.8

3.9

0.09

109

770

(36660697) Celiac disease serology panel - Serum

348

2838

1.25

3.68

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.12

3.64

1.1

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

130

2.16

3.57

1.0

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

122

860

1.43

3.53

1.4

ug/g

291.2

293.7

0.04

464

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

501

1.57

3.53

1.7

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.33

3.49

9.2

4.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

258

3228

0.79

3.48

1.7

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

243

1.82

3.48

1.7

2.1

—

2.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.34

3.47

10.2

10.4

mmol/l

5.5

6.0

0.31

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

105

723

1.46

3.44

1.3

1.2

u/ml

45.3

41.9

0.08

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

139

2.09

3.43

2.2

3.0

umol/l

206.0

172.6

0.09

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

189

1.91

3.33

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

189

1.91

3.33

1.3

1.6

u/l

7.0

6.7

0.05

161

(3008536) Aspergillus sp Ab [Presence] in Serum

2.72

3.32

1.9

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

680

1.47

3.30

5.8

4.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

128

2.12

3.29

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

115

2.18

3.28

3.1

2.5

—

(3000012) Reticulocyte production index

135

2.08

3.27

1.9

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

544

1.52

3.24

1.2

1.1

iu/ml

38.3

984.2

0.54

139

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.67

3.22

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

250

1.77

3.19

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

546

1.51

3.19

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.58

3.19

1.2

1.3

—

(3000330) Specific gravity of Urine by Test strip

190

1465

1.31

3.18

4.3

3.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.31

3.16

2.0

2.9

ng/l

178.1

153.4

0.20

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

382

1.61

3.11

1.8

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

367

1.62

3.09

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

592

1.48

3.07

3.9

3.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

146

1.99

3.04

1.8

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.84

3.02

1.0

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

162

1.92

2.94

1.5

nmol/l

1.3

0.04

128

(3023323) Follitropin [Units/volume] in Serum or Plasma

258

2094

1.25

2.90

1.7

1.4

iu/l

24.5

26.1

0.33

218

1785

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

813

7299

1.14

2.89

4.7

ug/l

3.8

2.8

0.35

724

6542

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

138

1032

1.35

2.88

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

289

2378

1.23

2.87

2.3

2.6

ml/min/173m2

66.5

69.7

0.56

120

912

(3049717) Cytology report of Urine Cyto stain

126

930

1.37

2.86

2.2

2.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

439

1.54

2.85

1.4

—

(3022145) Colonoscopy Study observation

393

3344

1.19

2.78

1.3

—

(3017704) Immunofixation for Urine

145

1.94

2.74

1.2

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.01

2.72

2.6

3.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

534

1.47

2.71

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

146

1.92

2.69

1.8

1.6

—

(4010399)

257

2108

1.23

2.65

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

169

1.84

2.62

1.8

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

3109

30274

1.13

2.55

20.9

13.8

39.4

39.8

2.19

2233

23087

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

238

1.69

2.54

1.4

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

2.23

2.53

1.5

1.3

99.6

104.2

0.26

(3032773) Endomysium IgG Ab [Titer] in Serum

308

1.60

2.52

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

352

4117

0.84

2.51

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

356

1.55

2.50

1.3

1.4

pmol/l

248.8

315.0

1.19

275

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

293

1.61

2.50

1.2

1.1

u/l

58.3

63.5

0.16

203

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.38

2.47

2.0

3.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.38

2.47

1.7

4.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

197

2428

0.80

2.40

1.5

—

(44790049)

360

1.54

2.40

1.6

—

(44806118)

360

1.54

2.40

1.6

—

(44790048)

360

1.54

2.40

1.6

—

(44790047)

360

1.54

2.40

1.6

—

(3015183) Erythrocyte sedimentation rate

208

0.38

2.40

1.0

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

6.26

2.37

2.6

1.8

mu/l

1.3

2.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

6.26

2.37

6.6

4.1

—

(3037756) Immunofixation for Serum or Plasma

525

1.44

2.36

1.5

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

646

1.39

2.30

1.7

1.5

nmol/l

0.4

0.15

521

(3025941) Bacteria identified in Stool by Culture

234

1933

1.22

2.29

1.4

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

317

1.55

2.27

4.8

5.6

mmol/l

7.1

0.00

265

(3025549) Creatine [Moles/time] in 24 hour Urine

3.48

2.27

1.8

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

127

977

1.31

2.25

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

156

1.80

2.25

1.5

nmol/l

5.9

3.5

0.21

121

(3013336) Amino acids [Identifier] in Serum or Plasma

3.89

2.25

7.9

3.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.89

2.25

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

255

1.61

2.23

1.3

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.10

2.22

1.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.11

2.22

1.3

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

528

0.60

2.19

3.1

3.8

u/ml

86.7

29.2

0.76

512

(3024891) Influenza virus A+B Ag [Presence] in Specimen

121

929

1.31

2.19

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

460

1.44

2.16

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

196

1.69

2.15

1.3

1.2

—

(4306422)

528

1.41

2.13

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

137

1.83

2.13

5.0

3.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

605

5436

1.13

2.12

1.3

u/ml

5.8

10.0

1.74

206

2198

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

482

1.42

2.05

1.3

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1049

0.73

2.05

1.8

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

457

1.43

2.04

1.7

1.6

—

(40768797) Stomach Pathology biopsy report

473

4196

1.14

2.02

1.3

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

125

1.84

2.02

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

166

1342

1.25

2.02

1.3

miu/ml

181.7

223.0

0.81

664

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

351

1.49

2.01

1.2

1.3

nmol/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

127

995

1.29

2.00

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.96

2.00

2.5

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

655

1.35

1.99

2.8

2.5

ug/min

193.0

104.2

0.58

410

(3021788) Differential panel - Synovial fluid

520

1.39

1.96

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

126

990

1.28

1.95

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.45

1.93

3.3

3.6

umol/l

33.0

46.2

1.44

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

314

1.50

1.92

1.6

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

558

0.64

1.92

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

211

1.62

1.91

2.1

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1172

0.75

1.91

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

267

1.54

1.89

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

639

5803

1.12

1.89

4.4

4.1

22.6

21.5

0.94

291

2698

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

340

1.48

1.89

1.7

1.6

54.6

59.5

0.33

213

(3034426) Prothrombin time (PT)

121

1.82

1.88

1.5

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

309

1.49

1.85

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.21

1.84

2.7

2.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1272

0.77

1.79

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

110

861

1.29

1.78

2.2

2.0

iu/l

4.9

4.5

0.13

312

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1045

0.75

1.77

1.3

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

264

1.52

1.76

2.2

2.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

257

2203

1.18

1.75

3.1

2.9

ng/l

193.5

184.1

0.12

234

1992

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

100

1278

0.78

1.74

1.3

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

281

1.50

1.74

1.3

1.1

—

27.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

147

1.71

1.73

1.6

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

217

1.57

1.73

1.1

ratio

1.1

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

100

1277

0.78

1.73

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

100

1276

0.78

1.72

1.3

1.4

—

(3036603) Volume of Urine

186

1.62

1.72

1.8

1.4

2001.0

2075.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.85

1.71

2.0

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

179

1.62

1.69

1.6

1.5

u/l

6.5

6.3

0.02

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.16

1.66

2.8

5.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.16

1.66

2.8

4.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

855

7941

1.10

1.65

1.6

mmol/l

1.4

0.84

720

6760

(3005033) Fetal Nuchal fold Thickness US

1043

0.76

1.64

1.3

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

573

1.33

1.63

2.1

1.9

pmol/l

168.8

196.2

1.45

538

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

150

1.67

1.63

1.6

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

445

1.38

1.62

1.4

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

229

1.53

1.62

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.57

1.61

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

184

2181

0.84

1.61

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

2.33

1.60

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

111

1381

0.80

1.57

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

110

1368

0.80

1.55

1.7

1.6

mg/l

5.8

3.9

0.53

953

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

256

1.49

1.55

1.6

1.5

32.6

32.3

0.02

159

(3024932) HLA-DR beta [Type]

107

1.78

1.54

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

658

1.30

1.54

1.5

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

359

0.61

1.53

1.3

1.6

mmol/l

7.3

7.6

0.26

220

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1076

0.78

1.52

1.4

1.5

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.86

1.50

1.0

u/ml

0.0

0.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

162

1.61

1.49

1.1

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

162

1.61

1.49

1.1

1.8

—

(3024471) HLA-A [Type]

109

1.75

1.46

1.1

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.50

1.45

2.4

4.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.73

1.43

1.2

1.4

—

(3045414) Leukocytes [Presence] in Urine

171

1448

1.19

1.40

1.8

1.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.25

1.40

1.3

1.7

—

(4198724)

173

1.56

1.39

1.2

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

255

1.46

1.38

4.9

3.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

280

1.43

1.37

3.1

2.5

—

(4038314)

2.94

1.36

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

357

1.38

1.35

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

207

1.50

1.35

1.1

nmol/l

1.7

6.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

349

1.38

1.34

1.5

1.3

—

31.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

113

1.68

1.31

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

113

1.68

1.31

1.5

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.81

1.31

1.5

3.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.81

1.31

1.9

1.3

umol/l

18.6

17.6

0.26

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.81

1.31

1.5

3.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

132

1575

0.83

1.29

1.5

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

390

3527

1.12

1.29

4.4

4.1

31.5

32.3

0.75

296

2447

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.05

1.26

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

219

1.47

1.25

1.7

1.3

—

(4212803)

2.40

1.24

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

140

1182

1.19

1.22

1.8

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.04

1.22

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

754

1.24

1.21

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

214

1.45

1.18

1.1

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

117

1.63

1.18

1.6

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

560

1.27

1.17

1.9

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

2.05

1.15

1.4

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

216

1.44

1.13

1.1

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

111

1.62

1.12

2.7

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

143

1.54

1.11

1.7

2.3

—

(3042517) Benzodiazepines panel - Urine

1.95

1.08

1.5

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

351

3845

0.90

1.04

1.7

1.8

—

(3003338) MCHC [Mass/volume]

2869

28191

1.07

1.04

24.8

16.3

g/l

331.9

332.6

3.06

2851

27978

(3011288) Drugs identified in Urine by Screen method

132

1128

1.18

1.04

2.6

3.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

349

1.32

1.04

2.6

2.2

mg/l

23.5

23.2

0.01

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.27

1.03

1.0

—

(3022670) pH of Venous cord blood

2.27

1.03

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

252

0.63

1.03

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

146

1.51

1.03

1.2

1.1

u/l

33.9

24.7

0.19

111

(40768793) Breast Pathology biopsy report

755

0.79

1.02

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

130

1.54

1.02

3.3

2.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

130

1.54

1.02

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

717

1.22

1.01

2.3

2.8

—

(3020393) Adenovirus Ag [Presence] in Stool

1.89

1.01

1.2

1.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.18

0.98

1.4

1.7

umol/24h

303.0

304.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

148

1.49

0.97

1.1

1.3

u/l

291.5

366.3

0.31

135

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

678

6383

1.08

0.97

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

113

961

1.18

0.96

3.0

3.5

u/ml

53.1

4372.9

0.87

816

(3045424) Erythrocytes [Presence] in Urine

532

1.24

0.96

1.7

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

901

0.82

0.95

1.4

1.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.95

0.0

1.0

—

6.9

—

(3035285) Chloride [Moles/volume] in Venous blood

320

1.32

0.94

2.7

2.5

mmol/l

105.1

105.5

0.21

315

(3041354) Potassium [Moles/volume] in Venous blood

320

1.32

0.94

2.7

2.5

mmol/l

4.0

0.35

315

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3179

31380

1.07

0.93

4.7

4.4

mmol/l

2.7

2.8

3.05

2951

29201

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

269

1.34

0.92

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

235

2114

1.12

0.91

1.2

—

(3019977) pH of Arterial blood

143

1.47

0.89

1.5

3.2

7.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

153

0.59

0.88

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

387

4180

0.92

0.88

1.8

1.5

1.4

1.49

343

3708

(3045142) Bone marrow Pathology biopsy report

324

1.30

0.88

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

230

1.35

0.84

1.0

—

(4211845)

154

1.43

0.83

2.4

3.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.69

0.82

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.69

0.82

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.69

0.82

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.69

0.82

1.0

1.1

—

(3008898) HLA-B27 [Presence]

154

1363

1.14

0.81

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

122

1.48

0.80

1.4

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

312

1.28

0.79

2.7

2.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

233

1.33

0.79

1.4

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.79

0.0

1.0

—

9.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.67

0.78

1.7

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.67

0.78

2.2

2.0

mmol/l

1.3

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

474

0.78

1.2

1.4

mmol/l

6.5

7.2

0.89

340

(3006462) Nitrate [Presence] in Urine

140

1.43

0.76

2.5

3.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

186

0.64

0.76

2.0

2.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.77

0.76

1.2

—

(4024509)

288

1.29

0.75

1.5

—

(3022621) pH of Urine by Test strip

226

2057

1.10

0.75

3.2

2.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

306

1.28

0.75

1.3

1.4

mmol/l

11.4

12.6

0.55

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.08

0.74

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

168

1505

1.12

0.74

2.2

2.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

236

1.32

0.74

1.4

1.2

—

(3000285) Sodium [Moles/volume] in Blood

1.84

0.73

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.64

0.73

1.4

1.9

—

(3035880) pH of Pleural fluid

132

0.61

0.73

1.3

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.00

0.72

2.0

4.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

276

0.72

0.71

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.62

0.71

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.75

0.71

1.4

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

112

1275

0.87

0.71

2.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

229

0.70

14.7

12.6

nmol/l

767.0

848.7

0.24

221

(3004451) EKG impression Narrative

126

1.43

0.70

1.1

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.85

0.68

1.6

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

556

1.19

0.68

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

275

1.28

0.68

1.3

1.4

titre

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.79

0.66

1.6

1.4

mmol/l

—

6.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

328

0.76

0.66

1.4

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

225

0.71

0.65

1.3

—

(4015189)

1.57

0.65

2.6

2.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

537

0.82

0.64

1.4

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

634

1.17

0.64

1.4

ug/l

2.4

4.1

2.50

584

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

278

1.26

0.63

2.0

1.9

ug/l

21.3

21.7

0.02

273

(3003888) Timothy IgE Ab [Units/volume] in Serum

761

0.85

0.62

1.1

u/ml

7.6

6.2

0.18

433

(3003129) Base excess in Capillary blood by calculation

1.59

0.61

1.2

1.4

mmol/l

3.4

0.5

—

(3004775) Volume in Urine collected for unspecified duration

217

1.29

0.61

2.4

667.1

614.7

0.36

147

(3045788) Cell count panel - Pleural fluid

245

0.73

0.61

1.3

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

1.60

0.61

1.6

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

468

4434

1.06

0.60

1.6

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

2.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3124

30933

1.05

0.60

4.3

4.1

mmol/l

4.6

4.7

4.34

2921

28972

(3020491) Glucose [Moles/volume] in Blood

236

1.27

0.59

1.6

1.9

mmol/l

6.5

6.6

0.04

169

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

254

1.26

0.59

1.5

1.3

u/ml

1.3

1.2

0.03

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

157

1.34

0.59

1.9

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

157

1.34

0.59

1.9

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

157

1.34

0.59

1.9

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

594

0.84

0.57

2.2

2.4

umol/l

5.5

6.4

0.42

437

(3019174) dRVVT (LA screen)

1.72

0.57

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.67

0.56

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.46

0.56

1.6

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

172

0.70

0.56

1.2

1.6

—

(3025130) Human papilloma virus identified in Specimen

541

1.17

0.55

1.9

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.62

0.55

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.62

0.55

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

691

1.15

0.55

1.6

1.7

e6/l

7188.4

12974.4

1.83

499

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.58

0.54

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.54

0.53

1.8

1.6

ng/l

96.5

127.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

447

0.83

0.52

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

250

1.24

0.52

1.2

1.1

u/ml

19.9

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

618

0.86

0.51

1.0

1.1

—

(44813793)

242

1.24

0.51

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

758

7321

1.04

0.49

1.7

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

101

1.39

0.49

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

746

1.13

0.49

2.0

2.1

—

(44806071)

1.52

0.48

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

292

2756

1.06

0.46

3.7

4.1

ug/l

36.4

18.7

0.25

234

2192

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.38

0.46

2.6

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

129

1.32

0.45

2.1

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

120

0.67

0.45

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

619

0.87

0.44

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

130

1.31

0.43

2.1

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

157

1.28

0.43

1.9

1.7

—

(1002224) Polysomnography panel

145

1338

1.09

0.43

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.56

0.42

2.8

2.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.56

0.42

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

131

1.30

0.42

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

158

1.27

0.41

2.2

1.7

u/field

1.1

4.1

1.36

115

(3008401) Mugwort IgE Ab [Units/volume] in Serum

732

0.89

0.41

1.1

u/ml

2.1

1.2

0.23

351

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.52

0.41

5.8

2.7

mg/l

1.0

1.3

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

231

1.21

0.41

3.1

2.1

u/field

4.1

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

439

4210

1.05

0.41

3.0

ug/l

0.7

0.03

286

2699

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

250

1.20

0.40

1.2

—

(3002256) Pathology report gross observation

422

4047

1.05

0.40

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

106

1.32

0.39

5.4

13.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

251

1.20

0.39

1.4

1.5

promille

1.4

1.3

0.09

196

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

196

1.23

0.39

1.0

1.4

pmol/l

78.1

192.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

233

1.20

0.38

2.4

2.2

—

(3035933) Granulocytes/100 leukocytes in Blood

147

0.75

0.37

1.1

1.6

—

(3002619) Bacteria identified in Specimen by Culture

1.31

0.37

1.3

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.43

0.35

1.2

1.6

pmol/l

26.6

32.3

—

(40768795) Lymph node Pathology biopsy report

282

1.17

0.35

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

660

1.11

0.35

1.7

1.8

—

(3001556) Androgen free Index in Serum or Plasma

1.40

0.35

1.2

1.1

—

(21494434) Karyotype in Bone marrow

255

1.18

0.34

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

647

0.89

0.34

1.7

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.32

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

128

1.25

0.31

1.9

2.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

305

0.85

0.31

1.3

1.4

e6/l

1221.0

2366.0

1.24

215

(3003694) ABO and Rh group [Type] in Blood

947

9670

0.97

0.31

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

371

1.13

0.30

1.7

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

129

1.24

0.30

2.1

1.8

—

(40765096) Chromosome analysis panel by Banding

1.29

0.30

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

372

1.13

0.30

1.7

1.4

—

(3027944) Amphetamines [Presence] in Urine

153

1622

0.94

0.29

2.4

2.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

231

1.17

0.29

1.0

1.1

u/ml

0.2

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

271

0.85

0.29

1.2

1.4

e6/l

34130.3

84346.3

0.57

185

(3020874) Milk IgE Ab [Units/volume] in Serum

250

1.16

0.29

1.1

u/ml

0.4

2.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

227

0.84

0.28

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

374

1.12

0.28

1.7

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.29

0.28

1.5

1.2

mg/l

1.0

80.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.27

0.27

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

375

1.12

0.27

1.7

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

161

0.81

0.27

2.0

1.9

—

(3028300) Cannabinoids [Presence] in Urine

157

1655

0.95

0.26

2.3

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

558

1.09

0.26

1.1

—

(44806420)

0.69

0.26

2.2

2.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.69

0.26

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

435

0.90

0.25

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.22

0.25

8.2

6.1

—

(3027008) Opiates [Presence] in Urine

157

1651

0.95

0.25

2.3

2.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

378

1.11

0.24

1.7

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

188

1966

0.95

0.24

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

538

0.91

0.24

1.0

1.1

u/ml

2.0

3.7

1.05

268

(3037556) Urate [Mass/volume] in Serum or Plasma

0.71

0.24

1.2

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

190

0.84

0.23

1.4

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.32

0.23

1.2

2.0

mg/l

1.1

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.28

0.23

2.8

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

670

1.08

0.22

1.2

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

381

1.10

0.22

1.7

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3088

30737

1.02

0.22

4.3

4.0

mmol/l

1.4

1.5

3.51

2864

28645

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.22

0.22

7.0

8.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

459

1.09

0.21

4.0

3.1

nmol/l

0.8

0.35

353

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3000492) Spirometry study

322

3126

1.03

0.21

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

440

1.09

0.21

1.2

u/l

26.9

40.4

0.65

380

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.2

—

(4094501)

751

1.07

0.20

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.25

0.20

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

432

1.09

0.20

1.1

g/l

1.5

0.35

390

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

758

0.94

0.20

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

118

1.19

0.19

2.6

3.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

270

0.89

0.19

1.3

1.4

e6/l

75026.1

86141.5

0.06

157

(3038177) Helicobacter pylori Ab [Presence] in Serum

581

0.93

0.18

1.1

1.2

—

(42870560) Thyrotropin [Units/volume] in Cord blood

1.24

0.18

1.0

mu/l

9.8

8.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

589

1.07

0.18

1.1

u/ml

5.6

4.5

0.16

240

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

213

1.13

0.18

1.2

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.21

0.18

1.0

1.3

—

(3012441) Differential panel - Pleural fluid

252

1.11

0.17

1.1

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

514

5238

0.98

0.17

2.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

711

0.94

0.16

1.1

u/ml

3.5

2.2

0.22

186

(3000764) Benzodiazepines [Presence] in Urine

158

1638

0.96

0.16

2.3

2.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

120

1.17

0.16

1.0

—

(4133840)

0.77

0.15

1.0

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

188

1822

1.03

0.15

2.8

3.0

u/ml

56.6

44.5

0.19

182

1756

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

121

1.16

0.15

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

462

4703

0.98

0.15

2.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

294

1.09

0.14

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.08

0.14

1.3

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

169

1.12

0.14

1.0

ng/l

864.2

717.0

0.49

105

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

131

1.15

0.14

1.5

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

264

0.91

0.14

1.5

—

(3044941) Cell count panel - Synovial fluid

470

0.94

0.14

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.82

0.13

1.0

1.4

ug/l

15.0

8.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

539

1.06

0.13

1.1

u/ml

7.5

4.4

0.43

234

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2974

29643

1.01

0.13

3.9

3.6

mmol/l

1.3

3.02

2762

27495

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

171

1.11

0.12

1.0

ng/l

40.8

45.5

0.23

105

(3003434) Protein [Mass/volume] in Pleural fluid

317

1.07

0.12

1.4

1.5

g/l

29.2

32.5

0.88

285

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

116

0.86

0.12

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

101

975

1.04

0.11

1.1

u/ml

1.2

4.3

2.51

134

(3014271) Vancomycin [Susceptibility]

124

1.13

0.11

3.5

2.8

—

(4281824)

332

0.93

0.11

1.2

—

(4034850)

105

1016

1.03

0.11

12.1

9.0

—

(40768441) Liver Pathology biopsy report

239

0.92

0.10

1.4

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

202

1.09

0.10

4.2

6.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.14

0.10

1.2

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

497

1.05

0.09

1.1

u/ml

0.8

0.3

0.41

130

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

165

1.09

0.08

1.1

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.07

0.08

1.2

2.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

324

3195

1.02

0.08

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.79

0.08

1.0

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.04

0.08

6.0

6.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

132

1291

1.02

0.08

2.5

2.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

264

1.06

0.07

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

264

1.06

0.07

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

264

1.06

0.07

1.7

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

125

1278

0.98

0.07

1.7

1.6

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

1.05

0.07

1.0

kpa

4.9

3.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.04

0.07

1.4

1.2

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

1.04

0.07

1.0

kpa

7.1

7.2

—

(3006598) pH of Arterial cord blood

1.04

0.07

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

108

1.11

0.07

1.6

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

193

1961

0.98

0.07

1.3

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

326

0.95

0.07

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.89

0.06

1.0

mmol/l

20.5

19.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

336

0.95

0.06

1.1

—

(3020650) Glucose [Presence] in Urine

0.85

0.06

1.8

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

244

0.94

0.06

1.1

iu/ml

9.6

9.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

141

0.92

0.05

1.1

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

337

1.04

0.04

3.0

4.6

u/ml

23.9

80.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

130

1.08

0.04

1.1

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

170

1.06

0.04

1.0

ng/l

305.2

310.4

0.04

108

(3051387) C reactive protein [Mass/volume] in Capillary blood

666

1.02

0.04

3.5

mg/l

27.1

25.7

0.12

422

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

832

0.99

0.02

1.2

1.1

u/ml

1.7

1.6

0.05

378

(40768806) Pleura Pathology biopsy report

261

1.03

0.02

1.3

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2332

23345

1.00

0.02

3.4

3.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

848

0.99

0.01

1.7

1.5

pmol/l

142.3

153.8

0.10

830

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

198

1.01

0.00

1.2

1.4

mmol/l

6.6

5.6

0.54

190

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

145

1.03

0.00

1.0

1.1

u/ml

5.3

6.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

136

1358

1.00

0.00

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

135

1355

1.00

0.00

1.5

—

(3016879) Cocaine [Presence] in Urine

152

1525

1.00

0.00

2.3

2.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

161

0.99

0.00

1.4

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

551

1.00

0.00

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

249

2491

1.00

0.00

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

263

0.99

0.00

1.6

1.7

—

(3024263) Appearance of Synovial fluid

153

0.98

0.00

1.2

1.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.93

0.00

1.4

1.7

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

34.9

—

(3048879) Bone marrow aspiration report

0.90

0.00

2.7

1.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.2

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.94

0.00

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

119.3

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

18.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.94

0.00

1.5

3.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

6.8

—

79.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.94

0.00

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.93

0.00

2.8

1.7

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.94

0.00

1.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.94

0.00

3.0

6.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.94

0.00

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

325.3

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

0.0

3.6

—

2.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.92

0.00

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.01

0.00

1.1

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

2.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.94

0.00

1.0

1.3

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1140.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_OPTNERVE and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_OPTNERVE	1.564 [1.39, 1.75]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.218

During the follow-up period (1.1.1998 — 31.12.2019), 1571 out of 11910 females with H7_OPTNERVE died.

Males

Parameter	HR [95% CI]	p-value
H7_OPTNERVE	1.746 [1.56, 1.95]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 1787 out of 8355 males with H7_OPTNERVE died.

Mortality risk

Mortality risk for people of age

years, who have H7_OPTNERVE.

N-year risk	Females	Males
1	0.211%	0.338%
5	0.888%	2.093%
10	2.284%	4.916%
15	4.457%	9.159%
20	7.639%	15.306%

Relationships between endpoints

↥

Index endpoint: H7_OPTNERVE – Disorders of optic nerve and visual pathways

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of optic nerve and visual pathways

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints